[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]




Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
страница8/8
Дата15.10.2012
Размер217.57 Kb.
ТипДокументы
1   2   3   4   5   6   7   8
Photochem Photobiol , 2005

Uebelhoer NS; Dover JS. Photodynamic therapy for cosmetic applications. Dermatol Ther 18 (3): 242-252, 2005

Uehara M; Sekine J; Wang Z; Inokuchi T. Morphometric analysis of mouse tumor nuclei subjected to photodynamic therapy. J Oral Maxillofac Surg 63 (2): 244-246, 2005

Usmani N; Stables GI; Telfer NR; Stringer MR. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy. J Am Acad Dermatol 53 (5 Suppl 1): S273-S276, 2005

Usui T; Sugisaki K; Amano S; Jang WD; Nishiyama N; Kataoka K. New Drug Delivery for Corneal Neovascularization Using Polyion Complex Micelles. Cornea 24 (8 Suppl 1): S39-S42, 2005

Uzdensky A; Kolosov M; Bragin D; Dergacheva O; Vanzha O; Oparina L. Involvement of adenylate cyclase and tyrosine kinase signaling pathways in response of crayfish stretch receptor neuron and satellite glia cell to photodynamic treatment. Glia 49 (3): 339-348, 2005

Uzdensky A; Kolpakova E; Juzeniene A; Juzenas P; Moan J. The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells. Biochim Biophys Acta 1722 (1): 43-50, 2005

Vakrat-Haglili Y; Weiner L; Brumfeld V; Brandis A; Salomon Y; McLlroy B; Wilson BC; Pawlak A; Rozanowska M; Sarna T; Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J Am Chem Soc 127 (17): 6487-6497, 2005

Van de MA; Sandhu SS; Kak R; Mitchell KW; Talks SJ. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112 (11): 1896-1903, 2005

Van de PM; Roskams T; Vandenheede JR; Agostinis P; de Witte PA. Elucidation of the tumoritropic principle of hypericin. Br J Cancer 92 (8): 1406-1413, 2005

van Duijnhoven FH; Tollenaar RA; Terpstra OT; Kuppen PJ. Locoregional therapies of liver metastases in a rat CC531 coloncarcinoma model results in increased resistance to tumour rechallenge. Clin Exp Metastasis 22 (3): 247-253, 2005

van Duijnhoven FH; Rovers JP; Engelmann K; Krajina Z; Purkiss SF; Zoetmulder FA; Vogl TJ; Terpstra OT. Photodynamic therapy with 5,10,15,20-tetrakis(m-hydroxyphenyl) bacteriochlorin for colorectal liver metastases is safe and feasible: results from a phase I study. Ann Surg Oncol 12 (10): 808-816, 2005

Varano M; Parisi V; Tedeschi M; Sciamanna M; Gallinaro G; Capaldo N; Catalano S; Pascarella A. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Invest Ophthalmol Vis Sci 46 (4): 1453-1462, 2005

Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 152 (4): 765-772, 2005

Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol : 1-6, 2005

Vogeser M; Schaffer M; Egeler E; Spohrer U. Development of an HPLC method for monitoring of Photofrin II therapy. Clin Biochem 38 (1): 73-78, 2005

Volanti C; Hendrickx N; Van Lint J; Matroule JY; Agostinis P; Piette J. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24 (18): 2981-2991, 2005

Wachtlin J; Bechrakis NE; Foerster MH. [Photodynamic therapy with verteporfin for uveal melanoma]. Ophthalmologe 102 (3): 241-246, 2005

Wachtlin J; Stroux A; Wehner A; Heimann H; Foerster MH. Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV. Graefes Arch Clin Exp Ophthalmol 243 (5): 438-445, 2005

Wagner SJ; Skripchenko A; Donnelly DJ; Ramaswamy K; Detty MR. Chalcogenoxanthylium photosensitizers for the photodynamic purging of blood-borne viral and bacterial pathogens. Bioorg Med Chem 13 (21): 5927-5935, 2005

Waki R; Gamo S; Bessho M; Hara M. Patterning cultured cells by visible light illumination with photosensitizers. J Biosci Bioeng 100 (3): 331-334, 2005

Wang HW; Zhu TC; Putt ME; Solonenko M; Metz J; Dimofte A; Miles J; Fraker DL; Glatstein E; Hahn SM; Yodh AG. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt 10 (1): 14004, 2005

Wanner M. Laser hair removal. Dermatol Ther 18 (3): 209-216, 2005

Webber J; Leeson B; Fromm D; Kessel D. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor. J Photochem Photobiol B 78 (2): 135-140, 2005

Weersink RA; Forbes J; Bisland S; Trachtenberg J; Elhilali M; Brun PH; Wilson BC. Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients. Photochem Photobiol 81 (1): 106-113, 2005

Weersink RA; Bogaards A; Gertner M; Davidson SR; Zhang K; Netchev G; Trachtenberg J; Wilson BC. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 79 (3): 211-222, 2005

Wei HJ; Xing D; Lu JJ; Gu HM; Wu GY; Jin Y. Determination of optical properties of normal and adenomatous human colon tissues in vitro using integrating sphere techniques. World J Gastroenterol 11 (16): 2413-2419, 2005

Weinberger D; Ron Y; Lusky M; Gaaton D; Orenstein A; Blank M; Mandel M; Livnat T; Barliya T; Lavie G. Competitive quenching: a possible novel approach in protecting RPE cells from damage during PDT. Curr Eye Res 30 (4): 269-277, 2005

Wennberg AM. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 46 Suppl: S3-S4, 2005

Wheeland RG. The pitfalls of treating all actinic keratoses as squamous cell carcinomas. Semin Cutan Med Surg 24 (3): 152-154, 2005

Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mossner J; Caca K. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder]. Z Gastroenterol 43 (3): 305-315, 2005

Wild PJ; Krieg RC; Seidl J; Stoehr R; Reher K; Hofmann C; Louhelainen J; Rosenthal A; Hartmann A; Pilarsky C; Bosserhoff AK; Knuechel R. RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther 4 (4): 516-528, 2005

Wilson B; Gude L; Fernandez MJ; Lorente A; Grant KB. Tunable DNA photocleavage by an acridine-imidazole conjugate. Inorg Chem 44 (18): 6159-6173, 2005

Wilson JD; Bigelow CE; Calkins DJ; Foster TH. Light scattering from intact cells reports oxidative-stress-induced mitochondrial swelling. Biophys J 88 (4): 2929-2938, 2005

Witjes JA; Moonen PM; van der Heijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study. Eur Urol 47 (3): 319-322, 2005

Witkin AJ; Duker JS. Optical coherence tomography of the vitreomacular interface in photodynamic therapy. Br J Ophthalmol 89 (7): 929, 2005

Wolfsen HC. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. Gastrointest Endosc 62 (4): 499-503, 2005

Wolfsen HC. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia. Expert Rev Med Devices 2 (6): 713-723, 2005

Wolfsen HC. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Compr Ther 31 (2): 137-144, 2005

Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol 39 (3): 189-202, 2005

Wolfsen HC. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 39 (8): 653-664, 2005

Wong RF; Bhutani MS. Therapeutic endoscopy and endoscopic ultrasound for gastrointestinal malignancies. Expert Rev Anticancer Ther 5 (4): 705-718, 2005

Wong TW; Wang YY; Sheu HM; Chuang YC. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother 49 (3): 895-902, 2005

Wormald R; Evans J; Smeeth L; Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 4: CD002030, 2005

Wu Y; Xing D; Luo S; Tang Y; Chen Q. Detection of caspase-3 activation in single cells by fluorescence resonance energy transfer during photodynamic therapy induced apoptosis. Cancer Lett , 2005

Xu T; Li Y; Wu X. Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy. Lasers Med Sci 19 (4): 257-261, 2005

Xue LY; Chiu SM; Oleinick NL. Differential responses of Mcl-1 in photosensitized epithelial vs lymphoid-derived human cancer cells. Oncogene 24 (46): 6987-6992, 2005

Yamada H; Arai T; Endo N; Yamashita K; Nonogawa M; Makino K; Fukuda K; Sasada M; Uchiyama T. Photodynamic effects of a novel pterin derivative on a pancreatic cancer cell line. Biochem Biophys Res Commun 333 (3): 763-767, 2005

Yamaguchi S; Tsuda H; Takemori M; Nakata S; Nishimura S; Kawamura N; Hanioka K; Inoue T; Nishimura R. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology 69 (2): 110-116, 2005

Yamamoto J; Hirano T; Li S; Koide M; Kohno E; Inenaga C; Tokuyama T; Yokota N; Yamamoto S; Terakawa S; Namba H. Selective accumulation and strong photodynamic effects of a new photosensitizer, ATX-S10.Na (II), in experimental malignant glioma. Int J Oncol 27 (5): 1207-1213, 2005

Yan F; Tao Z; Jia T; Xiao B; Chi H; Chen S. [The photodynamic therapy effect of a new cationic porphyrin on human laryngeal cancer Hep-2 cell in vitro]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19 (9): 399-402, 2005

Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia. Int J Oncol 27 (1): 193-201, 2005

Yang N; Fan CM; Ho CK. Review of first year result of photodynamic therapy on age-related macular degeneration in chinese population. Eye , 2005

Yano T; Muto M; Minashi K; Ohtsu A; Yoshida S. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 62 (1): 31-36, 2005

Yarze JC. Use of a transparent hood to facilitate photodynamic therapy of esophageal neoplasms. Gastrointest Endosc 61 (2): 350, 2005

Yee KK; Soo KC; Olivo M. Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex(R) in the treatment of human nasopharyngeal carcinoma. Int J Mol Med 16 (6): 993-1002, 2005

Yim YC; Lee ES; Chung PS; Rhee CK. Recalcitrant palmoplantar pustular psoriasis successfully treated with topical 5-aminolaevulinic acid photodynamic therapy. Clin Exp Dermatol 30 (6): 723-724, 2005

Yogo T; Urano Y; Ishitsuka Y; Maniwa F; Nagano T. Highly efficient and photostable photosensitizer based on BODIPY chromophore. J Am Chem Soc 127 (35): 12162-12163, 2005

Yoshida K; Kusuzaki K; Matsubara T; Matsumine A; Kumamoto T; Komada Y; Naka N; Uchida A. Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange. Oncol Rep 13 (2): 279-282, 2005

Yslas EI; Rivarola V; Durantini EN. Synthesis and photodynamic activity of zinc(II) phthalocyanine derivatives bearing methoxy and trifluoromethylbenzyloxy substituents in homogeneous and biological media. Bioorg Med Chem 13 (1): 39-46, 2005

Yu G; Durduran T; Zhou C; Wang HW; Putt ME; Saunders HM; Sehgal CM; Glatstein E; Yodh AG; Busch TM. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res 11 (9): 3543-3552, 2005

Yukruk F; Dogan AL; Canpinar H; Guc D; Akkaya EU. Water-soluble green perylenediimide (PDI) dyes as potential sensitizers for photodynamic therapy. Org Lett 7 (14): 2885-2887, 2005

Zaak D; Karl A; Knuchel R; Stepp H; Hartmann A; Reich O; Bachmann A; Siebels M; Popken G; Stief C. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 96 (2): 217-222, 2005

Zacal N; Espiritu M; Singh G; Rainbow AJ. Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells. Biochem Biophys Res Commun 331 (2): 648-657, 2005

Zakhary K; Ellis DA. Applications of aminolevulinic Acid-based photodynamic therapy in cosmetic facial plastic practices. Facial Plast Surg 21 (2): 110-116, 2005

Zalla JA. CPT coding and reimbursement issues in dermatology. Semin Cutan Med Surg 24 (3): 117-123, 2005

Zanin IC; Goncalves RB; Junior AB; Hope CK; Pratten J. Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 56 (2): 324-330, 2005

Zegner VG; Ashurov ZM; Sloeva AI. [Treatment of patients with respiratory papillomatosis: experience analysis]. Vestn Ross Akad Med Nauk (5): 25-28, 2005

Zelickson B; Counters J; Coles C; Selim M. Light patch: preliminary report of a novel form of blue light delivery for the treatment of actinic keratosis. Dermatol Surg 31 (3): 375-378, 2005

Zhang B; Miao L; Zhang Z; Xiao M; Chen M. [An experimental study on destruction of K562 and HL60 induced by 5-aminolaevulinic acid-based photodynamic therapy]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 22 (3): 525-529, 2005

Zhang X; Jiang F; Zhang ZG; Kalkanis SN; Hong X; Decarvalho AC; Chen J; Yang H; Robin AM; Chopp M. Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain. Lasers Med Sci 20 (2): 74-79, 2005

Zhao B; Xie J; Zhao J. Binding of hypocrellin B to human serum albumin and photo-induced interactions. Biochim Biophys Acta 1722 (2): 124-130, 2005

Zheng G; Chen J; Li H; Glickson JD. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci U S A , 2005

Zheng JC; Zhao H; Chen B; Wu Z; Jiang HW; Ding Q; Zhang YF. [Effect of new photosensitizer CDHS801-mediated photodynamic therapy on bladder cancer: an experimental study.]. Zhonghua Yi Xue Za Zhi 85 (25): 1762-1765, 2005

Zhou GY; Zhang ZY; Zhang CP; Zhu HG; Sun J; Gu JZ. [Clinical study on laser therapy of the venous malformations and hemangioma in oral and maxillofacial regions]. Zhonghua Kou Qiang Yi Xue Za Zhi 40 (3): 200-202, 2005

Zhou J; Liu J; Feng Y; Wei S; Gu X; Wang X; Zhang B. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B. Bioorg Med Chem Lett 15 (12): 3067-3070, 2005

Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother Pharmacol 56 (6): 569-577, 2005

Zhu TC; Finlay JC; Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B 79 (3): 231-241, 2005

Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Photochem Photobiol 81 (1): 96-105, 2005

Zoepf T; Jakobs R; Arnold JC; Apel D; Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100 (11): 2426-2430, 2005

Zouboulis CC; Rohrs H. [Cryosurgical treatment of actinic keratoses and evidence-based review.]. Hautarzt 56 (4): 353-359, 2005

1   2   3   4   5   6   7   8

Похожие:

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница